ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

The Cancer Letter Wins Investigative Reporting Award

June 8, 2001

DCT Contract Funds To Be 20 Percent less In FY 1986 Than In 1985; To Eliminate ‘Low Priority’ Contracts

February 14, 1986

States Spent Only 3.2% Of Settlement Money On Smoking Cessation.

November 21, 2008

Walter Curran Succeeds Brian Leyland-Jones As Director Of Emory’s Cancer Center

September 25, 2009

IOM Report Calls For FDA Authority Nutritional Supplement Health Claims

May 21, 2010

Thyroid Cancer Briefing Planned

July 8, 1977